RNAC
Cartesian Therapeutics Inc.
Company Overview
| Mkt Cap | $216.34M | Price | $8.17 |
| Volume | 33.56K | Change | +0.74% |
| P/E Ratio | -2.8 | Open | $8.13 |
| Revenue | $38.3M | Prev Close | $8.11 |
| Net Income | $-77.4M | 52W Range | $7.88 - $26.50 |
| Div Yield | N/A | Target | $36.43 |
| Overall | 34 | Value | 40 |
| Quality | 52 | Technical | 10 |
No chart data available
Stock Overview
Updated DailyCartesian Therapeutics Inc. (RNAC) is a leading diversified company in the business industry, currently trading at $8.17 with a market capitalization of $216.34 million. The stock is approaching its 52-week lows, suggesting potential value opportunity, demonstrating unrated quality characteristics with a MarketXLS quality score of N/A.
Today's trading session shows RNAC with a volume of 34K shares. The stock opened up 0.25% from yesterday's close of $8.11. Current analyst estimates project earnings of $-2.11 per share for this year, with next year targeting $-3.49.
RNAC demonstrates concerning technical signals based on technical analysis. The company trades on the NSD exchange.
Key investment considerations for RNAC include concerning overall investment profile. The company offers a dividend yield of NA% and analyst price targets suggest potential upside of 345.9%. The stock shows elevated valuation levels based on valuation analysis.
Analysis generated on November 3, 2025 at 12:25 AM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | RNAC | $8.17 | +0.7% | 33.56K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Cartesian Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW